Lymphatic endothelium: Difference between revisions
Content deleted Content added
m →Further reading: Task 17 (BRFA trial): replace to-be-deprecated: |name-list-format= (13× replaced; usage: 13 of 15); empty parameters removed; |
Ira Leviton (talk | contribs) Fixed journal articles. |
||
| Line 1: | Line 1: | ||
The '''lymphatic endothelium''' is a specialised form of [[epithelium]], distinct from but similar to [[endothelium|vascular endothelium]]. A [[lymph]] [[capillary]] endothelial cell is distinct from other endothelial cells in that [[collagen fiber]]s are directly attached to its [[plasma membrane]]. |
The '''lymphatic endothelium''' is a specialised form of [[epithelium]], distinct from but similar to [[endothelium|vascular endothelium]]. A [[lymph]] [[capillary]] endothelial cell is distinct from other endothelial cells in that [[collagen fiber]]s are directly attached to its [[plasma membrane]]. |
||
Although [[lymphatic]]s were first described by [[Hippocrates]] in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 17th century by [[Gasparo Aselli]], they were ignored for centuries until in 1937 [[Howard Florey]] showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that [[VEGF-R3]] and [[VEGF-C]]/[[VEGF-D]] were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being [[LYVE-1]] (Jackson et al.,1999)<ref name="J.Cell Biol">{{cite journal | title = |
Although [[lymphatic]]s were first described by [[Hippocrates]] in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 17th century by [[Gasparo Aselli]], they were ignored for centuries until in 1937 [[Howard Florey]] showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that [[VEGF-R3]] and [[VEGF-C]]/[[VEGF-D]] were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being [[LYVE-1]] (Jackson et al., 1999)<ref name="J.Cell Biol">{{cite journal | title = LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan 1| journal = The Journal of Cell Biology| volume = 144| issue = 4| pages = 789–801| doi = 10.1083/jcb.144.4.789| year = 1999| last1 = Banerji| first1 = Suneale| last2 = Ni| first2 = Jian| last3 = Wang| first3 = Shu-Xia| last4 = Clasper| first4 = Steven| last5 = Su| first5 = Jeffrey| last6 = Tammi| first6 = Raija| last7 = Jones| first7 = Margaret| last8 = Jackson| first8 = David G.| pmid = 10037799| pmc = 2132933}}</ref> and [[PDPN|podoplanin]] (Kerjaschki, 1999).<ref name="American Journal of Pathology">{{cite journal|first1=Silvana|last1=Breiteneder-Geleff|first2=Afschin|last2=Soleiman|first3=Heinrich|last3=Kowalski|first4=Reinhard|last4=Horvat|first5=Gabriele|last5=Amann|first6=Ernst|last6=Kriehuber|first7=Katja|last7=Diem|first8=Wolfgang|last8=Weninger|first9=Erwin|last9=Tschachler|first10=Kari|last10=Alitalo|first11=Dontscho|last11=Kerjaschki|title = Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic andothelium|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1849992/|journal=American Journal of Pathology|volume=154|issue=2|pages=385–394|pmid=10027397|pmc=1849992|doi=10.1016/S0002-9440(10)65285-6|accessdate = April 4, 2021}}</ref> |
||
==See also== |
==See also== |
||
| Line 11: | Line 11: | ||
==Further reading== |
==Further reading== |
||
{{refbegin | 2}} |
{{refbegin | 2}} |
||
*{{cite journal |
*{{cite journal | author=Jackson DG |title=The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1 |journal=Trends in Cardiovascular Medicine |volume=13 |issue= 1 |pages= 1–7 |year= 2003 |pmid= 12554094 |doi=10.1016/S1050-1738(02)00189-5 }} |
||
*{{cite journal |
*{{cite journal | author=Banerji S |title=LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan |journal=Journal of Cell Biology |volume=144 |issue= 4 |pages= 789–801 |year= 1999 |pmid= 10037799 |doi=10.1083/jcb.144.4.789 | pmc=2132933 |name-list-style=vanc | author2=Ni J | author3=Wang SX | display-authors=3 | last4=Clasper | first4=S | last5=Su | first5=J | last6=Tammi | first6=R | last7=Jones | first7=M | last8=Jackson | first8=DG }} |
||
*{{cite journal |
*{{cite journal |vauthors=Cunnick GH, Jiang WG, Gomez KF, Mansel RE |title=Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model |journal=Biochemical and Biophysical Research Communications |volume=288 |issue= 4 |pages= 1043–1046 |year= 2001 |pmid= 11689016 |doi= 10.1006/bbrc.2001.5869 }} |
||
*{{cite journal |
*{{cite journal | author=Mouta Carreira C |title=LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis |journal=Cancer Research |volume=61 |issue= 22 |pages= 8079–84 |year= 2001 |pmid= 11719431 |name-list-style=vanc | author2=Nasser SM | author3=di Tomaso E | display-authors=3 | last4=Padera | first4=TP | last5=Boucher | first5=Y | last6=Tomarev | first6=SI | last7=Jain | first7=RK }} |
||
*{{cite journal |
*{{cite journal | author=Cursiefen C |title=Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin |journal=Investigative Ophthalmology & Visual Science |volume=43 |issue= 7 |pages= 2127–35 |year= 2002 |pmid= 12091407 |name-list-style=vanc | author2=Schlötzer-Schrehardt U | author3=Küchle M | display-authors=3 | last4=Sorokin | first4=L | last5=Breiteneder-Geleff | first5=S | last6=Alitalo | first6=K | last7=Jackson | first7=D }} |
||
*{{cite journal |
*{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proceedings of the National Academy of Sciences – U.S.A. |volume=99 |issue= 26 |pages= 16899–16903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |name-list-style=vanc | author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }} |
||
*{{cite journal |
*{{cite journal | author=Huang SS |title=Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1 |journal=Journal of Biological Chemistry |volume=278 |issue= 44 |pages= 43855–43869 |year= 2003 |pmid= 12912978 |doi= 10.1074/jbc.M306411200 |name-list-style=vanc | author2=Tang FM | author3=Huang YH | display-authors=3 | last4=Liu | first4=IH | last5=Hsu | first5=SC | last6=Chen | first6=ST | last7=Huang | first7=JS | doi-access=free }} |
||
*{{cite journal |
*{{cite journal | author=Clark HF |title=The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment |journal=Genome Research |volume=13 |issue= 10 |pages= 2265–2270 |year= 2003 |pmid= 12975309 |doi= 10.1101/gr.1293003 | pmc=403697 |name-list-style=vanc | author2=Gurney AL | author3=Abaya E | display-authors=3 | last4=Baker | first4=K | last5=Baldwin | first5=D | last6=Brush | first6=J | last7=Chen | first7=J | last8=Chow | first8=B | last9=Chu | first9=C }} |
||
*{{cite journal |
*{{cite journal | author=Gerhard DS |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Research |volume=14 |issue= 10B |pages= 2121–2127 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |name-list-style=vanc | author2=Wagner L | author3=Feingold EA | display-authors=3 | last4=Shenmen | first4=CM | last5=Grouse | first5=LH | last6=Schuler | first6=G | last7=Klein | first7=SL | last8=Old | first8=S | last9=Rasooly | first9=R }} |
||
*{{cite journal |
*{{cite journal | author=Otsuki T |title=Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries |journal=DNA Research |volume=12 |issue= 2 |pages= 117–126 |year= 2007 |pmid= 16303743 |doi= 10.1093/dnares/12.2.117 |name-list-style=vanc | author2=Ota T | author3=Nishikawa T | display-authors=3 | last4=Hayashi | first4=K | last5=Suzuki | first5=Y | last6=Yamamoto | first6=J | last7=Wakamatsu | first7=A | last8=Kimura | first8=K | last9=Sakamoto | first9=K | doi-access=free }} |
||
*{{cite journal |
*{{cite journal | author=Liu T |title=Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry |journal=Journal of Proteome Research |volume=4 |issue= 6 |pages= 2070–2080 |year= 2006 |pmid= 16335952 |doi= 10.1021/pr0502065 | pmc=1850943 |name-list-style=vanc | author2=Qian WJ | author3=Gritsenko MA | display-authors=3 | last4=Camp | first4=David G. | last5=Monroe | first5=Matthew E. | last6=Moore | first6=Ronald J. | last7=Smith | first7=Richard D. }} |
||
*{{cite journal |
*{{cite journal | author=Kimura K |title=Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes |journal=Genome Research |volume=16 |issue= 1 |pages= 55–65 |year= 2006 |pmid= 16344560 |doi= 10.1101/gr.4039406 | pmc=1356129 |name-list-style=vanc | author2=Wakamatsu A | author3=Suzuki Y | display-authors=3 | last4=Ota | first4=T | last5=Nishikawa | first5=T | last6=Yamashita | first6=R | last7=Yamamoto | first7=J | last8=Sekine | first8=M | last9=Tsuritani | first9=K }} |
||
*{{cite journal |
*{{cite journal | author=Nguyen VA |title=Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence |journal=Modern Pathology |volume=19 |issue= 2 |pages= 291–298 |year= 2006 |pmid= 16424896 |doi= 10.1038/modpathol.3800537 |name-list-style=vanc | author2=Kutzner H | author3=Fürhapter C | display-authors=3 | last4=Tzankov | first4=Alexandar | last5=Sepp | first5=Norbert |doi-access=free }} |
||
*{{cite journal |
*{{cite journal | author=Gu B |title=Expression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placenta |journal=Lymphatic Research and Biology |volume=4 |issue= 1 |pages= 11–17 |year= 2007 |pmid= 16569201 |doi= 10.1089/lrb.2006.4.11 |name-list-style=vanc | author2=Alexander JS | author3=Gu Y | display-authors=3 | last4=Zhang | first4=Yanping | last5=Lewis | first5=David F. | last6=Wang | first6=Yuping | pmc=3072054 }} |
||
*{{cite journal |
*{{cite journal | author=Llovet JM |title=A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis |journal=Gastroenterology |volume=131 |issue= 6 |pages= 1758–1767 |year= 2007 |pmid= 17087938 |doi= 10.1053/j.gastro.2006.09.014 |name-list-style=vanc | author2=Chen Y | author3=Wurmbach E | display-authors=3 | last4=Roayaie | first4=Sasan | last5=Fiel | first5=M. Isabel | last6=Schwartz | first6=Myron | last7=Thung | first7=Swan N. | last8=Khitrov | first8=Gregory | last9=Zhang | first9=Weijia }} |
||
{{refend}} |
{{refend}} |
||
Revision as of 18:48, 4 April 2021
The lymphatic endothelium is a specialised form of epithelium, distinct from but similar to vascular endothelium. A lymph capillary endothelial cell is distinct from other endothelial cells in that collagen fibers are directly attached to its plasma membrane.
Although lymphatics were first described by Hippocrates in 400BC and rediscovered as "milky veins in the gut of a well fed dog" in the 17th century by Gasparo Aselli, they were ignored for centuries until in 1937 Howard Florey showed that lymphatics enlarge in inflammation. At this stage vascular and lymphatic endothelia were seen to be morphologically distinct and lymphatic vessels considered less important. Later it was discovered that VEGF-R3 and VEGF-C/VEGF-D were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being LYVE-1 (Jackson et al., 1999)[1] and podoplanin (Kerjaschki, 1999).[2]
See also
References
- ^ Banerji, Suneale; Ni, Jian; Wang, Shu-Xia; Clasper, Steven; Su, Jeffrey; Tammi, Raija; Jones, Margaret; Jackson, David G. (1999). "LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan 1". The Journal of Cell Biology. 144 (4): 789–801. doi:10.1083/jcb.144.4.789. PMC 2132933. PMID 10037799.
- ^ Breiteneder-Geleff, Silvana; Soleiman, Afschin; Kowalski, Heinrich; Horvat, Reinhard; Amann, Gabriele; Kriehuber, Ernst; Diem, Katja; Weninger, Wolfgang; Tschachler, Erwin; Alitalo, Kari; Kerjaschki, Dontscho. "Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic andothelium". American Journal of Pathology. 154 (2): 385–394. doi:10.1016/S0002-9440(10)65285-6. PMC 1849992. PMID 10027397. Retrieved April 4, 2021.
Further reading
- Jackson DG (2003). "The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1". Trends in Cardiovascular Medicine. 13 (1): 1–7. doi:10.1016/S1050-1738(02)00189-5. PMID 12554094.
- Banerji S, Ni J, Wang SX, et al. (1999). "LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan". Journal of Cell Biology. 144 (4): 789–801. doi:10.1083/jcb.144.4.789. PMC 2132933. PMID 10037799.
- Cunnick GH, Jiang WG, Gomez KF, Mansel RE (2001). "Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model". Biochemical and Biophysical Research Communications. 288 (4): 1043–1046. doi:10.1006/bbrc.2001.5869. PMID 11689016.
- Mouta Carreira C, Nasser SM, di Tomaso E, et al. (2001). "LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis". Cancer Research. 61 (22): 8079–84. PMID 11719431.
- Cursiefen C, Schlötzer-Schrehardt U, Küchle M, et al. (2002). "Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin". Investigative Ophthalmology & Visual Science. 43 (7): 2127–35. PMID 12091407.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proceedings of the National Academy of Sciences – U.S.A. 99 (26): 16899–16903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Huang SS, Tang FM, Huang YH, et al. (2003). "Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1". Journal of Biological Chemistry. 278 (44): 43855–43869. doi:10.1074/jbc.M306411200. PMID 12912978.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Research. 13 (10): 2265–2270. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Research. 14 (10B): 2121–2127. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Otsuki T, Ota T, Nishikawa T, et al. (2007). "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries". DNA Research. 12 (2): 117–126. doi:10.1093/dnares/12.2.117. PMID 16303743.
- Liu T, Qian WJ, Gritsenko MA, et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry". Journal of Proteome Research. 4 (6): 2070–2080. doi:10.1021/pr0502065. PMC 1850943. PMID 16335952.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes". Genome Research. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
- Nguyen VA, Kutzner H, Fürhapter C, et al. (2006). "Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence". Modern Pathology. 19 (2): 291–298. doi:10.1038/modpathol.3800537. PMID 16424896.
- Gu B, Alexander JS, Gu Y, et al. (2007). "Expression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placenta". Lymphatic Research and Biology. 4 (1): 11–17. doi:10.1089/lrb.2006.4.11. PMC 3072054. PMID 16569201.
- Llovet JM, Chen Y, Wurmbach E, et al. (2007). "A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis". Gastroenterology. 131 (6): 1758–1767. doi:10.1053/j.gastro.2006.09.014. PMID 17087938.
 | This science article is a stub. You can help Wikipedia by expanding it. |